National Center for PTSD, VA Boston Healthcare System.
Health Outcomes of Military Exposure, Epidemiology Program, VHA Patient Care Services.
Psychol Trauma. 2023 Nov;15(8):1248-1258. doi: 10.1037/tra0001282. Epub 2022 Jun 2.
[Correction Notice: An Erratum for this article was reported online in on Jun 30 2022 (see record 2022-76274-001). In the original article, the following acknowledgment of funding was missing from the title page author note: "This material was based upon work supported by the United States Department of Veterans Affairs (VA), Veterans Health Administration, Patient Care Services, Health Outcomes Military Exposures Epidemiology Program as well as two VA Health Services Research and Development Service Grants "Validation of Modified DRRI Scales in a National Sample of OEF/OIF Veterans" (Project DHI 09-086, Dawne Vogt, Principal Investigator) and "Work and Family Functioning in Women Veterans: Implications for VA Service Use" (Project IIR 12-345, Dawne Vogt and Brian N. Smith, Principal Investigators)." All versions of this article have been corrected.] Objective: It is important to assess warfare experiences beyond direct combat exposure, as these exposures can negatively impact military veterans' health. Although two validated scales from the Deployment Risk and Resilience Inventory-2 [DRRI-2] together capture a broad range of stressful warfare experiences, the length of this combined measure (30 items) is prohibitively long for some settings. Therefore, the goal of this project was to develop and validate a short form Warfare Exposure measure (DRRI-2-WE-SF).
U.S. veterans deployed for the wars in Iraq and Afghanistan completed questionnaires across 2 studies (study 1, = 1046; study 2, = 7141) to develop and validate the DRRI-2 WE-SF.
Study 1 involved developing the DRRI-2 WE-SF, a 9-item self-report instrument with strong internal consistency (α = .86) and large correlations with the full Warfare Exposure measure ( = .97). In study 2, the DRRI-2 WE-SF again demonstrated high levels of reliability and validity and evidenced high levels of classification accuracy (89.7% correct classification) and significant time savings (all s > 39; all s < .05) in comparison to the full measure.
The DRRI-2 WE-SF is a psychometrically sound measure of direct exposures to warfare and its consequences. This measure of proximal warfare exposure retains the strong properties of the full measure while significantly reducing completion time. These properties make the DRRI-2 WE-SF a useful tool for efficiently evaluating proximal warfare exposure among individuals who have served in both combat and noncombat roles. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
评估战争经历超出直接战斗暴露非常重要，因为这些经历会对退伍军人的健康产生负面影响。虽然 Deployment Risk and Resilience Inventory-2 [DRRI-2] 的两个经过验证的量表共同捕捉了广泛的压力战争经历，但这种综合测量（30 项）对于某些情况来说过长。因此，本项目的目标是开发和验证一个简短的战争暴露量表（DRRI-2-WE-SF）。
美国在伊拉克和阿富汗部署的退伍军人在两项研究（研究 1，=1046；研究 2，=7141）中完成了问卷调查，以开发和验证 DRRI-2 WE-SF。
研究 1 涉及开发 DRRI-2 WE-SF，这是一种 9 项自我报告的仪器，具有很强的内部一致性（α=.86），与完整的战争暴露量表（=.97）有很大的相关性。在研究 2 中，DRRI-2 WE-SF 再次表现出高度的可靠性和有效性，在分类准确性方面表现出高水平（89.7%的正确分类），与完整量表相比，时间显著节省（所有 s > 39；所有 s <.05）。
DRRI-2 WE-SF 是一种对直接接触战争及其后果的心理测量准确的测量方法。这种接近战争暴露的测量方法保留了完整测量的强大特性，同时显著减少了完成时间。这些特性使 DRRI-2 WE-SF 成为一种在战斗和非战斗角色中都有服役的个体中评估近程战争暴露的有用工具。（PsycInfo 数据库记录（c）2023 APA，保留所有权利）。
